Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

202.83
-0.6600-0.32%
Post-market: 202.00-0.8300-0.41%18:35 EDT
Volume:1.55M
Turnover:316.23M
Market Cap:314.59B
PE:31.01
High:204.75
Open:204.75
Low:202.73
Close:203.49
52wk High:212.71
52wk Low:122.48
Shares:1.55B
Float Shares:1.54B
Volume Ratio:0.66
T/O Rate:0.10%
Dividend:3.13
Dividend Rate:1.54%
EPS(TTM):6.54
EPS(LYR):6.54
ROE:22.84%
ROA:8.19%
PB:6.46
PE(LYR):31.01

Loading ...

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

MT Newswires Live
·
Feb 10

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Economic Data Deluge

MT Newswires Live
·
Feb 10

U.S. Stock Futures Advance Ahead of Retail Sales Data; Treasury Yields Signal Rate Cut Bets

Stock News
·
Feb 10

Press Release: AstraZeneca results: FY and Q4 2025

Dow Jones
·
Feb 10

BUZZ-Tectonic shares plunge as AstraZeneca scraps rival relaxin drug

Reuters
·
Feb 10

AstraZeneca (AZN) Receives a Buy from UBS

TIPRANKS
·
Feb 10

Jefferies Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Feb 10

These Stocks Are Today's Movers: Spotify, AppLovin, TSMC, BP, ON Semi, Credo, Upwork, and More -- Barrons.com

Dow Jones
·
Feb 10

U.S. Stocks to Watch: AppLovin, TSMC, BP, ON Semi, Credo, Upwork, ZoomInfo, and More

Dow Jones
·
Feb 10

AstraZeneca Forecasts Steady Growth In 2026 On Strong Cancer Drug Demand, Shares Rise

Reuters
·
Feb 10

AstraZeneca CEO teases weight-loss drug candidate as profit meets target

Dow Jones
·
Feb 10

J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Feb 10

AstraZeneca Projects Double-Digit EPS Growth Following $18.5 Billion CSPC Pharma Partnership

Deep News
·
Feb 10

AstraZeneca Forecasts Mid-to-High Single-Digit Revenue Growth And Low Double-Digit Core EPS Increase For FY 2026, With Core Tax Rate Between 18%-22%

Benzinga
·
Feb 10

AstraZeneca Q4 Adj. EPS $2.12 Beats $2.09 Estimate, Sales $15.503B Beat $15.490B Estimate

Benzinga
·
Feb 10

AstraZeneca Forecasts Growth in 2026 as It Builds Drug Pipeline

Reuters
·
Feb 10

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Feb 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 09

AstraZeneca's Weight-Loss Drug Strategy in Focus -- Earnings Preview

Dow Jones
·
Feb 09

Joint Vaccine Venture Between Kangtai Biological and AstraZeneca Terminated Following Market Shifts

Deep News
·
Feb 08